NGGT001

BIOLOGICAL2 trials

Sponsors

Xiamen Ophthalmology Center Affiliated to Xiamen University, NGGT (Suzhou) Biotechnology Co., Ltd.

Conditions

Bietti Crystalline Corneoretinal DystrophyBietti's Crystalline Dystrophy

Early Phase 1

Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy

Active, not recruitingNCT06302608

Xiamen Ophthalmology Center Affiliated to Xiamen UniversityBietti's Crystalline Dystrophy

Start: 2023-02-08End: 2028-11-25Updated: 2026-08-17

Phase 1

Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy Subjects

Active, not recruitingNCT06706427

NGGT (Suzhou) Biotechnology Co., Ltd.Bietti Crystalline Corneoretinal Dystrophy

Start: 2024-03-21End: 2029-09-26Updated: 2026-08-12

Related Papers

Safety and Vision Outcomes Following Gene Therapy for Bietti Crystalline Dystrophy

JAMA Ophthalmology2025-01-099 citations